title: [ROLE OF CYTOMEDINES IN THE TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS ASSOCIATED WITH IMPAIRED SPERMATOGENESIS].
abstract: The efficiency and safety of tablet drug Vitaprost in the treatment of 35 patients with chronic abacterial prostatitis associated with impaired spermatogenesis were evaluated. The treatment course comprises the use of drug 1 tablet 2 times a day for 60 days. It was shown that Vitaprost had a positive effect on the basic parameters of spermatogenesis, helping to increase the number of sperm cells (28.8%), their mobility (17%), and viability (14.2%). The number of abnormal sperm cells at the same time decreased by 26.2%.
authors: B A
authors: BA
authors: Neymark
authors: A I
authors: AI
authors: Neymark
authors: A V
authors: AV
authors: Davydov
authors: I I
authors: II
authors: Klepikova
authors: N A
authors: NA
authors: Nozdrachev
authors: M V
authors: MV
authors: Razdorskaya
mesh_terms: D000293:Adolescent; D000328:Adult; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage* / Q000378:metabolism*; D011472:Prostatitis / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D013091:Spermatogenesis / Q000187:drug effects*; D013997:Time Factors
chemical_list: D010455:Peptides; C524164:Vitaprost; C053892:cytomedins